Log in

LFVN Lifevantage Corp NASDAQ · United States

Lifevantage (LFVN) news

Lifevantage Corp is a public biotech or pharmaceutical company listed on NASDAQ under the ticker LFVN, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Lifevantage news

We have not published a story on Lifevantage yet. When there is news, it will appear here.

What Lifevantage does

LifeVantage Corporation is a company focused on nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. It identifies, researches, develops, formulates and sells nutrigenomic activators, dietary supplements, weight management products, gut health products, skin and hair care products, and nootropics. Its flagship line is Protandim, and other lines include the MindBody GLP-1 System, the P84 System for gut health, TrueScience skin and hair care products, Liquid Collagen, Petandim for dogs, and AXIO nootropic and energy and hydration drink mixes. Products are sold through a commission-based direct sales model that uses independent consultants, in markets including the United States, Mexico, Canada, Japan, Taiwan, Thailand, Australia, New Zealand, the United Kingdom and several European countries. In October 2025 the company acquired the critical operating assets of LoveBiome, and it launched four of the acquired products in the United States during fiscal year 2026. It is also modernizing its digital commerce platform.

Product or programWhat it isStage
ProtandimFlagship line of scientifically validated dietary supplementssold
P84 SystemTwo-product activator system that helps regulate, repair and restore gut healthlaunched in the United States
MindBody GLP-1 SystemDietary supplement system, sold internationally as the MB Systemlaunched in Canada and Europe
TrueScienceSkin and hair care productssold
PetandimChewable companion supplement for dogsintroduced in Mexico
AXIONootropic and energy and hydration drink mixesAXIO X and AXIO Hydrate launched in the United States

Summarised from the company's 10-K filed Aug 27, 2026.

Lifevantage annual financials

LineFY ended Jun 30, 2026FY ended Jun 30, 2025
Research and development$1.0 million$1.4 million
Net income (loss)$5.1 million$9.8 million
Cash from operations$10.2 million$11.9 million
Cash and equivalents$14.9 million$20.2 million

Latest balance sheet, Jun 30, 2026 (10-K): cash and equivalents $14.9 million.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about Lifevantage

What is the ticker symbol of Lifevantage?

Lifevantage Corp trades under the ticker LFVN on NASDAQ.

Where is Lifevantage listed?

Lifevantage Corp is listed on NASDAQ.

Which country or territory is Lifevantage listed under?

Our directory records Lifevantage Corp under United States.

Does aibio.space cover Lifevantage?

aibio.space lists Lifevantage Corp among 2,820 public biotech companies and publishes its news here as stories appear.

What does Lifevantage develop?

LifeVantage Corporation is a company focused on nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. It identifies, researches, develops, formulates and sells nutrigenomic activators, dietary supplements, weight management products, gut health products, skin and hair care products, and nootropics.

What is Protandim from Lifevantage?

Protandim: Flagship line of scientifically validated dietary supplements Stage: sold.

What is P84 System from Lifevantage?

P84 System: Two-product activator system that helps regulate, repair and restore gut health Stage: launched in the United States.

Is Lifevantage profitable?

Lifevantage Corp reported net income of $5.1 million for the fiscal year ended Jun 30, 2026, and generated $10.2 million of cash from operations, per its annual report to the SEC.

How much does Lifevantage spend on research and development?

$1.0 million in the fiscal year ended Jun 30, 2026, per its annual report.

How much cash does Lifevantage have?

$14.9 million in cash at Jun 30, 2026, per its 10-K.

Investor discussion: Lifevantage

Members talk about Lifevantage (LFVN). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:LFVN on TradingView.

Listing details

Lifevantage Corp is a public biotech or pharmaceutical company listed on NASDAQ under the ticker LFVN, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Lifevantage Corp
Ticker
LFVN
Listing
NASDAQ
Country or territory
United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.